FDA Aims To Invigorate Sluggish Drug-Labeling Overhaul
Citing disappointing progress on improved prescription-drug labeling, the U.S. Food and Drug Administration said Tuesday that it was looking at providing the pharmaceutical industry with assistance to update drugs' safety information....To view the full article, register now.
Already a subscriber? Click here to view full article